Monthly FDA Guidance and Regulatory News Review - December 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Bridging Science and Regulatory Success with Medical Writing
As medical content evolves from focusing on technical and scientific information to also...
Monthly FDA Guidance and Regulatory News Review - November 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Monthly FDA Guidance and Regulatory News Review-October 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Biostatisticians: Ensuring the validity, reliability, and interpretability of clinical trial data
Discussion with Erin Mathias, Sr. Director, Global Biostatistics
Monthly FDA Guidance and Regulatory News Review-September 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Successful DMC Services for Complex Hematologic Cancer Trial
Learn how Veristat's expert biostatistics team worked with a longstanding global biopharma sponsor...
Understanding the Critical Role of Data Monitoring Committees in Clinical Trials
Learn how Veristat's expert teams develop and organize various independent Data Monitoring...
Monthly FDA Guidance and Regulatory News Review - August 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Cancer Research Trends | Key ASCO 2024 Takeaways
Discussion with Gabriela Rosu, MD, Sr. Director, Global Medical Affairs